English | Español

Pharmaceutical Research
Patient Daily | Jan 26, 2026

PhRMA: PBMs and insurers raise patient costs while restricting access
Patient Daily | Jan 16, 2026

PhRMA senior manager on PBMs: 'Drug spending is nearly 200% higher per patient at 340B hospitals'
Patient Daily | Jan 7, 2026

PhRMA warns of cancer drug markups, 340B program profiteering
Patient Daily | Dec 22, 2025

PhRMA Director on 340B: Hospitals are 'exploiting the program for profit'
Patient Daily | Dec 1, 2025

PhRMA Senior Director on 340B abuse: 'If Congress is serious about lowering drug costs, they must reform 340B'

Trending
+ Pharmaceuticals
Patient Daily | Jan 30, 2026

Senate gridlock delays decision on rare disease priority review voucher program
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor